Zoliflodacin

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Extensively drug-resistant (XDR) Neisseria gonorrhoeae cured with ceftriaxone 2 g intravenous monotherapy in Croatia, March 2026.

Extensively drug-resistant (XDR) Neisseria gonorrhoeae cured with ceftriaxone 2 g intravenous monotherapy in Croatia, March 2026.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: May 29, 2026

Zoliflodacin for Urogenital Gonorrhea Infections.

Zoliflodacin for Urogenital Gonorrhea Infections.

Journal: The Annals of pharmacotherapy

Published: May 28, 2026

Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrB D429N in Neisseria gonorrhoeae.

Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrB D429N in Neisseria gonorrhoeae.

Journal: bioRxiv : the preprint server for biology

Published: May 18, 2026

Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea.

Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea.

Journal: The Annals of pharmacotherapy

Published: April 11, 2026

Public contributions to the development of antibiotics: two successful and two failed investments.

Public contributions to the development of antibiotics: two successful and two failed investments.

Journal: Journal of pharmaceutical policy and practice

Published: April 01, 2026

Zoliflodacin: an oral, first-in-class antibacterial agent for drug-resistant gonorrhea.

Zoliflodacin: an oral, first-in-class antibacterial agent for drug-resistant gonorrhea.

Journal: Trends in pharmacological sciences

Published: March 31, 2026

Zoliflodacin: non-inferior, but not equivalent? - Authors' reply.

Zoliflodacin: non-inferior, but not equivalent? - Authors' reply.

Journal: Lancet (London, England)

Published: March 27, 2026

Two new drugs for gonorrhea.

Two new drugs for gonorrhea.

Journal: The Medical letter on drugs and therapeutics

Published: March 07, 2026

Zoliflodacin: First Approval.

Zoliflodacin: First Approval.

Journal: Drugs

Published: February 22, 2026

Bacterial DNA topoisomerase IV and DNA gyrase inhibitors: history of the quinolones, their clinical usage and potential alternatives for the future.

Bacterial DNA topoisomerase IV and DNA gyrase inhibitors: history of the quinolones, their clinical usage and potential alternatives for the future.

Journal: The Journal of antimicrobial chemotherapy

Published: February 19, 2026

The pharyngeal sanctuary: a challenge for zoliflodacin.

The pharyngeal sanctuary: a challenge for zoliflodacin.

Journal: Lancet (London, England)

Published: February 10, 2026

Zoliflodacin for uncomplicated gonorrhea: clinical evidence and implications beyond ceftriaxone plus azithromycin.

Zoliflodacin for uncomplicated gonorrhea: clinical evidence and implications beyond ceftriaxone plus azithromycin.

Journal: Annals of medicine and surgery (2012)

Published: February 10, 2026

Showing 1-12 of 98

Last Updated: 06/30/2026